FREE Case Review (866) 588-0600

Schmidt & Clark, LLP Contacted by Reglan Users Claiming Irreversible Side Effects, Including Tardive Dyskinesia

sc-no-longer-accepting-cases

FOR IMMEDIATE RELEASE

Schmidt & Clark, LLP, a mass torts law firm has reported receiving a significant number of inquiries from Reglan users claiming to suffer from serious side effects including a movement disorder known as Tardive Dyskineisa.

Approved in 1995, Reglan (Generic: metoclopramide) is a prescription medication that is designed to treat primarily gastro intestinal disorders, particularly, when there is a motility issue with the stomach or intestines. Reglan is indicated for short-term use although, a physician may sometimes determine to prescribe Reglan for a longer period of time and for other medical conditions.

Safety experts from the Duke University School of Medicine, publishing in the November/December 2004 Journal of the American Pharmacists Association, caution that the use of Reglan is increasing and that this fact may result in more cases of drug-induced movement disorders from the medication.

The U.S. Food & Drug Administration (FDA) has ONLY approved Reglan for short-term use (4 to 12 weeks) and ONLY when conservative treatment fails.

Long-term use of Reglan may cause a serious side effect known as Tardive Dyskinesia (TD). TD may be accompanied by very mild symptoms to a more severe form which causes a life-long and irreversible neurological movement disorders.

TD is characterized by repetitive, involuntary and purposeless movements. Signs of the disorder may include the following symptoms:

  • Involuntary jerking movements/spasms of the tongue, face, mouth and jaw.
  • Uncontrolled facial grimacing
  • Tongue protrusion
  • Lip smacking
  • Lip puckering/pursing
  • Rapid eye blinking
  • Uncontrollable movement in the arms, legs, and trunk
  • Involuntary movement on the hands and fingers

If you believe that you may have developed TD as a result of taking Reglan, it is important that you contact your physician and be evaluated.

Michael Schmidt, Managing Partner of Schmidt & Clark has noticed an alarming number of inquiries to the firm related to Reglan. Mr. Schmidt stated “We are a firm that focuses on mass torts litigation. As a result, we have received a large number of inquiries where the party has stated that they have been diagnosed with Tardive Dyskinesia after having taken Reglan. While there have been warnings regarding TD by the manufacturer, based on the number of calls to my office and the study cited by the Duke University School of Medicine and the Journal of the American Pharmacists Association, it would appear that the number of Reglan related TD cases and inquiries to my office may continue to rise.”

Leave a reply

Your email address will not be published.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*
Awards & recognition